[345] Raoult D, Levy PY, Harlé JR, Etienne J, Massip P, Goldstein F et al. Chronic Q fever: <strong>diagnosis</strong> <strong>and</strong> follow-up. Ann N Y Acad Sci 1990; 590:51-60. [346] Krauss H, Schmeer N, Schiefer HG. Epidemiology <strong>and</strong> significance <strong>of</strong> Q feber in the Federal Republic <strong>of</strong> Germany. Zentralbl Bakteriol Mikrobiol Hy A 1987; 267(1):41-50. [347] Fenollar F, Fournier PE, Carrieri MP et al. Risks factors <strong>and</strong> prevention <strong>of</strong> Q fever endocarditis. Clin Infect Dis 2001; 33:312. [348] Gikas A, K<strong>of</strong>teridis DP, Manios A et al. Newer macrolides as empiric treatment for acute Q fever infection. Antimicrob Agents Chemother 2001; 45:3644. [349] Limonard GJ, Peters JB, Nabuurs-Franssen MH, Weers-Poth<strong>of</strong>f G, Besselink R, Groot CA et al. Detailed analysis <strong>of</strong> health status <strong>of</strong> Q fever patients 1 year after the first Dutch outbreak: a case-control study. QJM 2010; 103(12):953-8. [350] Wegdam-Blans et al, The Dutch Q fever Consensus Group, © 2011 The British Infection As<strong>so</strong>ciation, published by Elsevier ltd. [351] Lienhard R et al, First Case <strong>of</strong> Anaplasma phagocytophilum Seroconversion <strong>and</strong> Seroepidemiology in Northern Switzerl<strong>and</strong>, 12 th International Conference on <strong>Lyme</strong> Borreliosis <strong>and</strong> other tick-borne <strong>disease</strong>s, September 26-29, 2010, Ljubljana, Slovenia. [352] Lommano E et al, Prevalence <strong>of</strong> Rickettsia spp, Babesia spp <strong>and</strong> Anaplasma phagocytophilum in questing Ixodes ricinus ticks from different sites in Switzerl<strong>and</strong>, 12 th International Conference on <strong>Lyme</strong> Borreliosis <strong>and</strong> other tick- borne <strong>disease</strong>s, September 26-29, 2010, Ljubljana, Slovenia. [353] Khanakah G et al, Anaplasma, Borrelia, Coxiella, Rickettsia in ticks removed from dogs, 12 th International Conference on <strong>Lyme</strong> Borreliosis <strong>and</strong> other tick- borne <strong>disease</strong>s, September 26-29, 2010, Ljubljana, Slovenia. 98
[354] Katargina O et al, Detection <strong>and</strong> Characterization <strong>of</strong> Babesia in Estonia, 12 th International Conference on <strong>Lyme</strong> Borreliosis <strong>and</strong> other tick-borne <strong>disease</strong>s, September 26-29, 2010, Ljubljana, Slovenia 99
- Page 1 and 2:
Infectiologic differential diagnosi
- Page 3 and 4:
3 Anamnistically, one has to consid
- Page 5 and 6:
Table 2 LD coinfections (not tick-b
- Page 7 and 8:
Table 5 Bartonellosis’ infection
- Page 9 and 10:
Table 6 Main disease manifestations
- Page 11 and 12:
11 Fig. 1. Erythrocytes infected wi
- Page 13 and 14:
13 Bartonellae are localized in ery
- Page 15 and 16:
ESR und CRP elevated Hypercalcemia
- Page 18 and 19:
Table 9 Antibiotic treatment of bar
- Page 20 and 21:
antibiosis is that the antibiotic i
- Page 22 and 23:
The laboratory diagnostics for Chla
- Page 24 and 25:
The arthritis occurs in 1% of the u
- Page 26 and 27:
In the differential diagnosis of Ly
- Page 28 and 29:
Late phase: - Reactive arthritis -
- Page 30 and 31:
the depiction of chronic yersiniosi
- Page 32 and 33:
In Yersinia-PCR-positive patients,
- Page 34 and 35:
- Incubation period 3 weeks - Atypi
- Page 36 and 37:
system, of the skin and other organ
- Page 38 and 39:
- Ehrlichia chaffeensis [1] - Anapl
- Page 40 and 41:
Since seroprevalence merely express
- Page 42 and 43:
B. microti is the predominant patho
- Page 44 and 45:
epresent a major health hazard and
- Page 46 and 47:
The decisive diagnostic information
- Page 48 and 49: Probable: IFA IgG 1:1024 and one of
- Page 50 and 51: The main manifestation of the Campy
- Page 52 and 53: The term “reactive arthritis” i
- Page 54 and 55: In the diagnosis of a “reactive a
- Page 56 and 57: Table 27 Disease manifestations of
- Page 58 and 59: addition, other pathogens discussed
- Page 60 and 61: [8] Schouls LM, Van De Pol I, Rijpk
- Page 62 and 63: [25] Hermanowska-Szpakowicz T, Skot
- Page 64 and 65: [43] Bakken JS, Krueth JK, Lund T,
- Page 66 and 67: [60] Fox LM, Wingerter S, Ahmed A e
- Page 68 and 69: [80] Marra CM. Neurologic complicat
- Page 70 and 71: [100] Pulliainen AT, Dehio C. Barto
- Page 72 and 73: [118] Bass JW, Freitas BC, Freitas
- Page 74 and 75: [137] Gaydos CA, Roblin PM, Hammers
- Page 76 and 77: [155] Cover TL, Aber RC. Yersinia e
- Page 78 and 79: multi-organ donors for the presence
- Page 80 and 81: [190] Straubinger RK, Straubinger A
- Page 82 and 83: [208] Bitnun A, Ford-Jones E, Blase
- Page 84 and 85: patients with reactive and undiffer
- Page 86 and 87: [242] Appelbaum PC, Gillespie SH, B
- Page 88 and 89: pneumoniae infection associated wit
- Page 90 and 91: [276] Thomas NH, Collins JE, Robb S
- Page 92 and 93: [294] File TM Jr, Segreti J, Dunbar
- Page 94 and 95: [310] Sorvillo FJ, Lieb LE, Waterma
- Page 96 and 97: henselae Isolates Collected from Ca